These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9044481)

  • 1. Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses.
    Papiris SA; Vlachoyiannopoulos PG; Maniati MA; Karakostas KX; Constantopoulos SH; Moutsopoulos HH
    Respiration; 1997; 64(1):81-5. PubMed ID: 9044481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CA 15-3 is increased in pulmonary fibrosis.
    Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Desai SR; Veeraraghavan S; Hansell DM; Nikolakopolou A; Goh NS; Nicholson AG; Colby TV; Denton CP; Black CM; du Bois RM; Wells AU
    Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
    Bouros D; Wells AU; Nicholson AG; Colby TV; Polychronopoulos V; Pantelidis P; Haslam PL; Vassilakis DA; Black CM; du Bois RM
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1581-6. PubMed ID: 12070056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Course of idiopathic pulmonary fibrosis of the Wells grade III at presentation. Study using high-resolution computerized tomography].
    Zompatori M; Fasano L; Battista G; Cavina M; Bertaccini P
    Radiol Med; 1997 Dec; 94(6):611-7. PubMed ID: 9524598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
    Schachna L; Medsger TA; Dauber JH; Wigley FM; Braunstein NA; White B; Steen VD; Conte JV; Yang SC; McCurry KR; Borja MC; Plaskon DE; Orens JB; Gelber AC
    Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
    Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
    J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
    Hoffmann-Vold AM; Tennøe AH; Garen T; Midtvedt Ø; Abraityte A; Aaløkken TM; Lund MB; Brunborg C; Aukrust P; Ueland T; Molberg Ø
    Chest; 2016 Aug; 150(2):299-306. PubMed ID: 26997242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.